BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Eradication rate
1
Precision therapy guided by genotypic antibiotic resistance for Helicobacter pylori eradication: A prospective, randomized controlled trial
11/13/2025 6:51:09 AM | Browse: 90 | Download: 119
2
Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial
7/24/2025 7:47:22 AM | Browse: 91 | Download: 284
3
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?
4/2/2025 10:54:13 AM | Browse: 186 | Download: 911
4
Vonoprazan-amoxicillin dual regimen with Saccharomyces boulardii as a rescue therapy for Helicobacter pylori: Current perspectives and implications
3/14/2024 5:31:16 PM | Browse: 201 | Download: 671
5
Success of susceptibility-guided eradication of Helicobacter pylori in a region with high secondary clarithromycin and levofloxacin resistance rates
1/12/2024 8:02:47 AM | Browse: 420 | Download: 1491
6
Statistical proof of Helicobacter pylori eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population
8/24/2022 11:31:49 AM | Browse: 461 | Download: 1598
7
Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
5/15/2017 6:16:31 AM | Browse: 1479 | Download: 2143
8
Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance
12/9/2015 5:57:00 PM | Browse: 1074 | Download: 2147
9
Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication
7/14/2015 12:17:00 PM | Browse: 1262 | Download: 2829
10
Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication
5/18/2015 5:02:00 PM | Browse: 1171 | Download: 2145
11
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease
4/27/2015 4:29:00 PM | Browse: 1350 | Download: 2477
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345